How I treat my inflammatory bowel disease-patients with thiopurines?

doi:10.4292/wjgpt.v7.i4.524

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8176)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

611

WORD

247

HTML

4351

Figures (1-1)

236

Tables (1-2)

163

Sum=5608

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1183

Download

1385

Sum=2568

Nov 6, 2016 (publication date) through Jun 28, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Pharmacol Ther. Nov 6, 2016; 7(4): 524-530
Published online Nov 6, 2016. doi: 10.4292/wjgpt.v7.i4.524

Table 1 Laboratory tests to determine risk of myelotoxicity and hepatotoxicity during initiation of thiopurine therapy

Hematologic parameters

Hemoglobin

White blood cell count

Platelet count

Hepatic parameters

Alkalic phosphatase

Gamma glutamyl transpeptidase

Alanine aminotransferase

Other parameters

Creatinine

C-reactive protein

Measuring of above mentioned parameters: Induction phase: week 0, 1, 2, 4, 8 and 12; Maintenance phase: Each 3-4 mo.

Citation: Meijer B, Mulder CJ, van Bodegraven AA, de Boer NKH. How I treat my inflammatory bowel disease-patients with thiopurines? World J Gastrointest Pharmacol Ther 2016; 7(4): 524-530
URL: https://www.wjgnet.com/2150-5349/full/v7/i4/524.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v7.i4.524